BR100 Increased By (0.52%)
BR30 Increased By (0.49%)
KSE100 Increased By (0.46%)
KSE30 Increased By (0.58%)
BECO 5.67 Decreased By ▼ -0.06 (-1.05%)
BML 57.03 Decreased By ▼ -0.27 (-0.47%)
BOP 36.88 Increased By ▲ 0.11 (0.3%)
CNERGY 8.32 Decreased By ▼ -0.07 (-0.83%)
DCL 11.94 Decreased By ▼ -0.10 (-0.83%)
FCCL 58.65 Increased By ▲ 0.04 (0.07%)
FCSC 5.10 Increased By ▲ 0.09 (1.8%)
FFL 18.11 Increased By ▲ 0.17 (0.95%)
FNEL 1.26 No Change ▼ 0.00 (0%)
HUMNL 11.19 Decreased By ▼ -0.23 (-2.01%)
KEL 8.25 Decreased By ▼ -0.04 (-0.48%)
KOSM 6.55 Decreased By ▼ -0.07 (-1.06%)
MLCF 107.66 Decreased By ▼ -0.63 (-0.58%)
NBP 208.82 Increased By ▲ 2.78 (1.35%)
PACE 11.14 Decreased By ▼ -0.03 (-0.27%)
PAEL 45.51 Increased By ▲ 0.16 (0.35%)
PIAHCLA 30.30 Decreased By ▼ -0.47 (-1.53%)
PIBTL 18.93 Decreased By ▼ -0.13 (-0.68%)
PPL 248.70 Increased By ▲ 2.75 (1.12%)
PRL 36.39 Increased By ▲ 0.31 (0.86%)
PTC 73.90 Increased By ▲ 1.54 (2.13%)
SEARL 96.10 Decreased By ▼ -0.57 (-0.59%)
SSGC 31.36 Decreased By ▼ -0.31 (-0.98%)
TELE 9.21 Decreased By ▼ -0.06 (-0.65%)
THCCL 68.10 Increased By ▲ 0.29 (0.43%)
TPLP 11.61 Increased By ▲ 0.38 (3.38%)
TREET 25.79 Decreased By ▼ -0.10 (-0.39%)
TRG 67.52 Decreased By ▼ -0.32 (-0.47%)
WAVES 11.21 Increased By ▲ 0.23 (2.09%)
WTL 1.28 No Change ▼ 0.00 (0%)
By

MUMBAI: India said on Sunday it was considering granting an emergency authorisation for a Covid-19 vaccine, particularly for the elderly and people in high-risk workplaces, as the country's number of reported infections passed 4.75 million.

India, which has consistently reported over 1,000 Covid-19 deaths daily this month, has now recorded 78,586 fatalities from the disease. It lags only the United States globally in overall number of infections, but it has been adding more daily cases than the United States since mid-August.

"India is considering emergency authorisation of a Covid-19 vaccination," said Health Minister Harsh Vardhan. "If there is a consensus we may go ahead with it, especially in the case of senior citizens and people working in high-risk settings."

Vardhan said the timeline on Phase III trials could be shortened by giving emergency authorisation, but stressed no corners would be cut in clinical trials and that a vaccine would only be made available when the government could ensure its safety and efficacy. He said no date has been set for a vaccine launch, but added results of trials should be clear by the first quarter of 2021.

Comments

Comments are closed for this article.